| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 168 | 2023 |
| Transdermal patches: Design and current approaches to painless drug delivery OA Al Hanbali, HMS Khan, M Sarfraz, M Arafat, S Ijaz, A Hameed Acta Pharmaceutica 69 (2), 197-215, 2019 | 167 | 2019 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 79 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 74 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 74 | 2024 |
| Nanosized liposomes containing bile salt: A vesicular nanocarrier for enhancing oral bioavailability of BCS class III drug M Arafat, C Kirchhoefer, MM Mikov, MK Sarfraz, R Löbenberg Canadian Society for Pharmaceutical Sciences, 2017 | 56 | 2017 |
| Approaches to achieve an oral controlled release drug delivery system using polymers: a recent review M Arafat Int J Pharm Pharm Sci 7 (7), 16-21, 2015 | 46 | 2015 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 44 | 2024 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 36 | 2024 |
| Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release. OA Al Hanbali, R Hamed, M Arafat, Y Bakkour, H Al-Matubsi, R Mansour, ... Pakistan Journal of Pharmaceutical Sciences 31, 2018 | 27 | 2018 |
| Capacity and willingness to use information technology for managing chronic diseases among patients: A cross-sectional study in Lahore, Pakistan S Iftikhar, A Saqib, MR Sarwar, M Sarfraz, M Arafat, Q Shoaib PloS one 14 (1), e0209654, 2019 | 26 | 2019 |
| Cefotaxime pharmacokinetics after oral application in the form of 3α, 7α-dihydroxy-12-keto-5β-cholanate microvesicles in rat S Golocorbin-Kon, M Mikov, M Arafat, Z Lepojevic, I Mikov, ... European journal of drug metabolism and pharmacokinetics 34, 31-36, 2009 | 26 | 2009 |
| Attitude, perception, willingness, motivation and barriers to practice-based research: A cross-sectional survey of hospital pharmacists in Lahore, Punjab, Pakistan MR Sarwar, A Saqib, T Riaz, H Aziz, M Arafat, H Nouman PloS one 13 (9), e0203568, 2018 | 24 | 2018 |
| Cross-linked guar gum and sodium borate based microspheres as colon-targeted anticancer drug delivery systems for 5-fluorouracil. T Kamal, M Sarfraz, M Arafat, M Mikov Pakistan Journal of Pharmaceutical Sciences 30, 2017 | 24 | 2017 |
| Butylglyceryl pectin nanoparticles: Synthesis, formulation and characterization MF Bostanudin, M Arafat, M Sarfraz, DC Górecki, E Barbu Polymers 11 (5), 789, 2019 | 23 | 2019 |
| Nano-sized droplets of self-emulsifying system for enhancing oral bioavailability of chemotherapeutic agent VP-16 in rats: A nano lipid carrier for BCS class IV drugs N Khalid, MK Sarfraz, M Arafat, M Akhtar, R Löbenberg Canadian Society for Pharmaceutical Sciences., 2018 | 21 | 2018 |
| Mixed micelles loaded with bile salt: an approach to enhance intestinal transport of the BCS class III drug cefotaxime in rats M Arafat, C Kirchhoefer, M Mikov European Journal of Drug Metabolism and Pharmacokinetics 42, 635-645, 2017 | 21 | 2017 |
| The measurement of cefotaxime sodium in rat plasma after oral administration: a sensitive HPLC-UV method M Arafat, S Golocorbin-kon, M Mikov Int J Pharm Pharm Sci 7 (4), 343-6, 2015 | 21 | 2015 |
| Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo … M Arafat, M Sarfraz, S AbuRuz Pharmaceuticals 14 (5), 479, 2021 | 20 | 2021 |
| Comparison between generic drugs and brand name drugs from bioequivalence and thermoequivalence prospective M Arafat, Z Ahmed, O Arafat Int. J. Pharm. Pharm. Sci 9 (1), 10.22159, 2017 | 20 | 2017 |
Muhammad SarfrazAssociate Professor, Al Ain University of science and technology.在 aau.ac.ae 的电子邮件经过验证
